临床儿科杂志
臨床兒科雜誌
림상인과잡지
2014年
8期
789-792
,共4页
李丽(综述)%李敏(审校)
李麗(綜述)%李敏(審校)
리려(종술)%리민(심교)
哮喘%气道重塑%白三烯受体拮抗剂%Th17细胞%CD4+CD25+treg细胞
哮喘%氣道重塑%白三烯受體拮抗劑%Th17細胞%CD4+CD25+treg細胞
효천%기도중소%백삼희수체길항제%Th17세포%CD4+CD25+treg세포
asthma%airway remodeling%leukotriene receptor antagonists%Th17 cells%CD4+CD25+treg cells
支气管哮喘的气道重塑是气道炎症反复作用的结果,白三烯是气道重塑中的重要炎症介质之一。影响气道重塑的因素较多,近年来Th17细胞和CD4+CD25+调节性T细胞(CD4+CD25+treg细胞)在气道重塑中的作用日益受到重视。白三烯受体拮抗剂是治疗哮喘的有效药物,能在一定程度上抑制气道重塑,但其作用机制及对Th17细胞/CD4+CD25+treg细胞表达的影响机制尚不十分清楚。因此,阐明Th17细胞/CD4+CD25+treg细胞平衡在气道重塑中的表达变化、白三烯受体拮抗剂干预气道重塑的具体作用途径和生物效应及对Th17细胞/CD4+CD25+treg细胞表达的影响,将为以后哮喘患儿的预防和治疗提供新的靶点。
支氣管哮喘的氣道重塑是氣道炎癥反複作用的結果,白三烯是氣道重塑中的重要炎癥介質之一。影響氣道重塑的因素較多,近年來Th17細胞和CD4+CD25+調節性T細胞(CD4+CD25+treg細胞)在氣道重塑中的作用日益受到重視。白三烯受體拮抗劑是治療哮喘的有效藥物,能在一定程度上抑製氣道重塑,但其作用機製及對Th17細胞/CD4+CD25+treg細胞錶達的影響機製尚不十分清楚。因此,闡明Th17細胞/CD4+CD25+treg細胞平衡在氣道重塑中的錶達變化、白三烯受體拮抗劑榦預氣道重塑的具體作用途徑和生物效應及對Th17細胞/CD4+CD25+treg細胞錶達的影響,將為以後哮喘患兒的預防和治療提供新的靶點。
지기관효천적기도중소시기도염증반복작용적결과,백삼희시기도중소중적중요염증개질지일。영향기도중소적인소교다,근년래Th17세포화CD4+CD25+조절성T세포(CD4+CD25+treg세포)재기도중소중적작용일익수도중시。백삼희수체길항제시치료효천적유효약물,능재일정정도상억제기도중소,단기작용궤제급대Th17세포/CD4+CD25+treg세포표체적영향궤제상불십분청초。인차,천명Th17세포/CD4+CD25+treg세포평형재기도중소중적표체변화、백삼희수체길항제간예기도중소적구체작용도경화생물효응급대Th17세포/CD4+CD25+treg세포표체적영향,장위이후효천환인적예방화치료제공신적파점。
The airway remodeling of bronchial asthma is the result of repeated airway inlfammation. Its occurrence is a complex process involving many cytokines, inlfammatory mediators and associated cellular components, of which leukotrienes are important mediators of inlfammation in the airway remodeling. Many factors inlfuence Airway remodeling. In recent years, effects of Th17 cells and CD4+CD25+regulatory T cells (CD4+CD25+treg cells) on airway remodeling is growing in importance. Leukotriene receptor antagonist is an effective drug in the treatment of asthma and can suppress airway remodeling. But the exact mechanisms and its impact on the proportion of Th17 cells/CD4+CD25+treg cells is not yet clear. Therefore, the clariifcation of the changes of Th17 cells/CD4+CD25+treg cells expression in airway remodeling and the speciifc pathways, biological effects, inlfuence of the proportion of Th17 cells/CD4+CD25+treg cells expression after leukotriene receptor antagonist intervene can provide a new target for prevention and the treatment of asthma in the future.